Nano+ Project Ends With Promising Results

Nano+ Project Ends With Promising Results

Currently with no known cure, Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord. InnoSer has recently finished a project with promising results in understanding altered...
A day in the life of InnoSer Oncology Study Director Kim Frederix

A day in the life of InnoSer Oncology Study Director Kim Frederix

To provide a range of innovative tools for accelerating drug development, InnoSer brings people from both scientific and business backgrounds together. With our interview series ‘A day in the life of’, let’s take a glimpse into what it is like to be part of this small...
InnoSers Ongoing Commitment to the 3Rs

InnoSers Ongoing Commitment to the 3Rs

Throughout modern medicine, animal testing has played a critical role in the development of drugs, vaccines, and surgical techniques. These studies have enabled us to save countless lives and build upon research to ultimately cure patients. Aiming to accelerate the...
InnoSer is at AACR with its Oncology Offerings

InnoSer is at AACR with its Oncology Offerings

Innoser is putting oncology development at the forefront of our efforts this year. By attending this year’s AACR 2021, we hope to improve our innovative oncology offerings and learn from the best. This year the American Association for Cancer Research is hosting...